Barbier Ann 4
4 · PIERIS PHARMACEUTICALS, INC. · Filed Jun 24, 2022
Insider Transaction Report
Form 4
Barbier Ann
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-22+40,000→ 40,000 totalExercise: $1.82Exp: 2032-06-22→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The stock option will vest as to 100% of the underlying shares on the date of the Company's 2023 annual stockholders meeting, subject to the Reporting Person's continued service as a director through the vesting date.